Drug-induced hypersensitivity syndrome associated with transient hypogammaglobulinaemia and increase in serum IgE level

Dermatology

Volumn 210, Issue 4, 2005, Pages 349-352

  Nakashima, H ^a,b   Yamane, K ^a   Ihn, H ^a   Nakamura, K ^a   Watanabe, R ^a   Kuwano, Y ^a   Takekoshi, T ^a   Watanabe, T ^a   Hattori, N ^a   Fujimoto, M ^a   Tamaki, K ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b University of Tokyo   (Japan)

Author keywords

Cytokines; Human herpesvirus; Hypersensitivity syndrome; Hypogammaglobulinaemia; Immunoglobulin E; Immunoglobulin G

Indexed keywords

AMOBARBITAL; BROMISOVAL; BROTIZOLAM; CARBAMAZEPINE; CHLORPROMAZINE; CORTICOSTEROID; GAMMA INTERFERON; HALOPERIDOL; IMMUNOGLOBULIN E; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; LEVOMEPROMAZINE; MEPREDNISONE; PAROXETINE; PERPHENAZINE; PREDNISOLONE; VIRUS DNA;

ADULT; ANTIBODY TITER; ANXIETY DISORDER; ARTICLE; CASE REPORT; CONFUSION; CORTICOSTEROID THERAPY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; EOSINOPHIL; FEMALE; HUMAN; HUMAN HERPESVIRUS 6; HYPERIMMUNOGLOBULINEMIA E; HYPOGAMMAGLOBULINEMIA; LABORATORY TEST; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; VIRUS REACTIVATION;

ADULT; AGAMMAGLOBULINEMIA; DRUG HYPERSENSITIVITY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN E; IMMUNOSUPPRESSIVE AGENTS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 22144445307     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000084765     Document Type: Article

References (26)

1. Roujeau JC, Stem RS: Severe adverse cutaneous reactions to drugs. N Engl J Med 1994;331:1272-1285.
2. Fujino Y, Nakajima M, Inoue H, Kusuhara T, Yamada T: Human herpesvirus 6 encephalitis associated with hypersensitivity syndrome. Ann Neurol 2002;51:771-774.
3. Sekine N, Motokura T, Oki T, Umeda Y, Sasaki N, Hayashi M, Sato H, Fujita T, Kaneko T, Asano Y, Kikuchi K: Rapid loss of insulin secretion in a patient with fulminant type 1 diabetes mellitus and carbamazepine hypersensitivity syndrome. JAMA 2001;285:1153-1154.
4. Prussick R, Shear NH: Dapsone hypersensitivity syndrome. J Am Acad Dermatol 1996;35:346-349.
5. Mok CC, Lau CS: Dapsone syndrome in cutaneous lupus erythematosus. J Rheumatol 1996;23:766-768.
6. Aihara Y, Ito SI, Kobayashi Y, Yamakawa Y, Aihara M, Yokota S: Carbamazepine-induced hypersensitivity syndrome associated with transient hypogammaglobulinaemia and reactivation of human herpesvirus 6 infection demonstrated by real-time quantitative polymerase chain reaction. Br J Dermatol 2003;149:165-169.
7. Tohyama M, Hashimoto K: Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6. Arch Dermatol 1998;134:1113-1137.
8. Suzuki Y, Inagi R, Aono T, Yamanishi K, Shiohara T: Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome. Arch Dermatol 1998;134:1108-1112.
9. Chopra S, Levell NJ, Cowley G: Systemic corticosteroids in the phenytoin hypersensitivity syndrome. Br J Dermatol 1996;134:1109-1112.
10. MacNeil M, Haase DA, Tremaine R, Marrie TJ: Fever, lymphadenopathy, eosinophilia, lymphocytosis, hepatitis, and dermatitis: A severe adverse reaction to minocycline. J Am Acad Dermatol 1997;36:347-350.
11. Tas S, Simonart T: Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome): An update. Dermatology 2003;206:353-356.
12. Han T, Chawla PL, Sokal JE: Sulfapyridine-induced serum-sickness-like syndrome associated with plasmacytosis, lymphocytosis and multiclonal gamma-globulinopathy. N Engl J Med 1969;280:547-548.
13. Mihas AA, Goldenberg DJ: Sulfasalazine toxic reactions. JAMA 1978;289:2590-2591.
14. Kanner RS, Tedesco FJ, Kaiser MH: Azulfidine- (sulfasalazine-) induced hepatic injury. Am J Dig Dis 1978;23:956-958.
15. Sotolongo RP, Neefe LI, Rudzki C, Ishak KG: Hypersensitivity reaction to sulfasalazine with severe hepatotoxicity. Gastroenterology 1978;75:95-99.
16. Callot V, Roujeau JC, Bagot M, Wechsler J, Chosidow O, Souteyrand P, Morel P, Dubertret L, Avril MF, Revuz J: Drug-induced pseudolymphoma and hypersensitivity syndrome: Two different clinical entities. Arch Dermatol 1996;132:1315-1321.
17. Vittorio CC, Muglia JJ: Anticon vulsant hypersensitivity syndrome. Arch Intern Med 1995;155:2285-2290.
18. Descamps V, Valance A, Edlinger C, Fillet AM, Grossin M, Lebrun-Vignes B, Belaich S, Crickx B: Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms. Arch Dermatol 2001;137:301-304.
19. van Ginneken EEM, van der Meer JWM, Netten PM: A man with a mysterious hypogammaglobulinemia and skin rash. Neth J Med 1999;54:158-162.
20. Horneff G, Lenard HG, Wahn V: Severe adverse reaction to carbamazepine: Significance of humoral and cellular reactions to the drug. Neuropediatrics 1992;23:272-275.
21. Kano Y, Inaoka M, Shiohara T: Association between anticonvulsant hypersensitivity syndrome and human herpesvirus 6 reactivation and hypogammaglobulinemia. Arch Dermatol 2004;140:183-188.
22. Kim IJ, Flano E, Woodland DL, Blackman MA: Antibody-mediated control of persistent γ-herpesvirus infection. J. Immunol 2002;168:3958-3964.
23. Scerri L, Shall L, Zaki I: Carbamazepine-induced anticonvulsant hypersensitivity syndrome - Pathogenic and diagnostic considerations. Clin Exp Dermatol 1993;18:540-542.
24. Galindo Bonilla PA, Romero Aguilera G, Feo Brito F, Gomez Torrijos E, Garcia Rodriguez R, Cortina de la Calle P, Encinas Barrios C: Phenytoin hypersensitivity syndrome with positive patch test: A possible cross-reactivity with amitriptyline. J Invest Allergol Clin Immunol 1998;8:186-190.
25. Mauri-Hellweg D, Bettens F, Mauri D, Brander C, Hunziker T, Pichler WJ: Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenytoin, and carbamazepine. J Immunol 1995;155:462-472.
26. Frenkel N, Schirmer EC, Katsafanas G, June CH: T-cell activation is required for efficient replication of human herpesvirus 6. J Virol 1990;64:4598-4602.